| Authors | Country | Age at cataract diagnosis (yrs) | T1DM duration at diagnosis (yrs) | HbA1c at T1DM diagnosis (%) | Mean HbA1c (%) | Morphology of cataract | Gender female/male | Surgical treatment | Number of patients |
| Phillip et al. [6] | USA | 14 | 0 | 17 | / | PSC | 1/0 | 0 | 1 | Alouf and Pascual [7] | USA | 9 | 0 | 22.2 | / | S | 1/0 | 0 | 1 | Datta et al. [8] | UK | 11 to 14 | 0 to 1 | 15.1 to 21.2 | / | PSC, S, C, D | 3/2 | 4 | 5 | Montgomery and Batch [9] | Australia | 9 to 16 | 0 to 13 | 7.2 to 15.2 | 6.5 to >14 | PSC, C | 8/1 | 8 | 9 | Falck and Laatikainen [10] | Finland | 9.1 to 17.5 | 0 to 3.9 | / | / | PSC, S, DI | 5/1 | 6 | 6 | Awan et al. [11] | UK | 18 | 0 | 10.5 | / | C, D | 0/1 | 1 | 1 | Wilson et al. [5] | Multiple | 5 to 16.5 | / | / | / | Multiple | 11/3 | 12 | 14 | Costagliola et al. [12] | Italy | 5.3 to 13.2 | 0 to 0.1 | 12.8 to 14.5 | / | PSC, S, D, DI | 0/3 | 3 | 3 | Patel et al. [13] | USA | 10 | 0 | 17.9 | 13.4 | PSC, C, DI | 0/1 | 1 | 1 | Skrabic et al. [14] | Croatia | 16.8 | 0.2 | 15.5 | 11.7 | PSC | 1/0 | 1 | 1 | Iafusco et al. [15] | Italy | 5.5 to 15 | 0 to 0.2 | 12.8 to >14 | 8 to 11.6 | PSC, S, D, DI | 3/3 | 5 | 6 | Uspal and Schapiro [16] | USA | 13 | 0 | >14 | / | D | 1/0 | 1 | 1 | Jin et al. [17] | China | 9 to 11 | 0 | 30 to 31 | 14.7 to 20.4 | PSC, S, C, D | 2/0 | 0 | 2 | Goturu et al. [18] | UK | 13.3 | 0.3 | 16.6 | 11.6 | PSC | 1/0 | 1 | 1 | Geloneck et al. [3] | USA | 7.5 to 18 | 0 to 15 | 7.7 to >14 | 7.3 to >14 | PSC, C, D | / | 5 | 12 | García García and García Robles [19] | Spain | 12 to 13 | 0.5 to 10 | 14 to 14.5 | 8.7 to 10 | S, C, DI | 1/1 | 1 | 2 |
|
|